Doxazosin effects on insulin and glucose in hypertensive patients
- 30 April 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (4) , 1307-1311
- https://doi.org/10.1016/0002-8703(91)90438-n
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effects of doxazosin on serum lipids: A review of the clinical data and molecular basis for altered lipid metabolismAmerican Heart Journal, 1991
- Pharmacotherapeutic stature of doxazosin and its role in coronary risk reductionAmerican Heart Journal, 1988
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987
- An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertensionPublished by Elsevier ,1987
- Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertensionThe American Journal of Cardiology, 1987
- Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.Published by Wiley ,1986
- Multicentre 12‐week double‐blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- Epidemiology of coronary heart disease: The Framingham studyThe American Journal of Medicine, 1984
- Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy.Circulation, 1982